Kiniksa Pharmaceuticals International (KNSA) Treasury Shares (2017 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Treasury Shares came in at $1.9 million in Q2 2026, down 18.43% YoY from $2.3 million in Q2 2025, and down 7.67% on a QoQ basis from $2.0 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Treasury Shares (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 10 years of Treasury Shares data on file, last reported at $1.9 million in Q2 2026.
- Quarterly Treasury Shares fell 18.43% year-over-year to $1.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 million (down 18.43% YoY) and the FY2025 annual result came in at $2.1 million, down 7.84% from the prior year.
- Treasury Shares slipped to $1.9 million in Q2 2026, from $2.0 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.4 million in Q4 2023 to a low of $665770.0 in Q1 2022.
- A 5-year average of $2.0 million and a median of $2.1 million in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares jumped 148.75% — and 2026, when it fell 18.43%.
- Tracing KNSA's Treasury Shares over 5 years: stood at $1.7 million in 2022, then soared by 37.56% to $2.4 million in 2023, then fell by 6.1% to $2.3 million in 2024, then declined by 7.84% to $2.1 million in 2025, then decreased by 10.63% to $1.9 million in 2026.
- The last three Treasury Shares figures came in at $1.9 million (Q2 2026), $2.0 million (Q1 2026), and $2.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 19.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 6.07 Bn | 5.54 Bn | 220.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 Mn |
| Jun 30, 2026 | 1.85 Mn |
| Mar 31, 2026 | 2.01 Mn |
| Mar 31, 2026 | 2.01 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.27 Mn |
| Jun 30, 2025 | 2.27 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 2.26 Mn |
| Mar 31, 2024 | 2.26 Mn |